What is GlucoTrack Inc (GCTK) stock price today?

GlucoTrack Inc (GCTK) currently trades at $0.85 per share. The stock has a market capitalization of $1.55M and a P/E ratio of —x.

Is GCTK stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, GlucoTrack Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -39.30.

Is GlucoTrack Inc financially healthy?

GlucoTrack Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -39.30 places it in the distress.

GCTK

GlucoTrack Inc

NASDAQ: GCTK · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$0.85

-7.26% today

Updated 2026-04-30

Market cap

$1.55M

P/E ratio

—

P/S ratio

526.95x

EPS (TTM)

$-31.22

Dividend yield

—

52W range

$1 – $14

Volume

3.5M

Market cap

$1.55M

P/E ratio

—

P/S ratio

526.95x

EPS (TTM)

$-31.22

Dividend yield

—

52W range

$1 – $14

Volume

3.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-39.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -39.30 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.96M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-4.43M	$-7.10M	$-22.60M	$-19.39M	$-3.63M
EPS	—	—	—	—	$-31.22
Free cash flow	$-3.73M	$-6.56M	$-12.59M	$-15.34M	$-3.96M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GCTK	$1.55M	26	4.3	3.0	5.0	5.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

GlucoTrack Inc trades at $0.85. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -39.30, it sits in the distress.

Frequently asked questions

What is GlucoTrack Inc's stock price?

GlucoTrack Inc (GCTK) trades at $0.85.

Is GlucoTrack Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of GlucoTrack Inc (GCTK)?

The analyst target price is $—, representing NaN% downside from the current price of $0.85.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-39.30 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL INSTRUMENTS & SUPPLIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

glucotrack.com

Quick metrics

P/S ratio526.95x

ROE-1,491.00%

Beta0.61

50D MA$1.23

200D MA$4.49

Shares out0.00B

Float0.00B

Short ratio—

Avg volume3.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GCTK vs LLY →GCTK vs JNJ →GCTK vs ABBV →Stock screener →